(Q40156217)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

18 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Mechanistic analysis and comparison of viral fusogenic membrane proteins for their synergistic effects on chemotherapy (English)

1 reference

18 September 2017

1 reference

Dennis Hoffmann

1

1 reference

18 September 2017

Thomas Grunwald

series ordinal

2

1 reference

18 September 2017

Seraphin Kuate

series ordinal

3

1 reference

18 September 2017

Oliver Wildner

series ordinal

4

1 reference

18 September 2017

language of work or name

1 reference

1 April 2007

1 reference

Cancer Biology and Therapy

18 September 2017

published in

1 reference

18 September 2017

volume

6

1 reference

18 September 2017

issue

4

1 reference

18 September 2017

page(s)

510-518

1 reference

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

18 September 2017

cites work

Surfing the p53 network

1 reference

30 December 2023

Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Feedback control of cyclooxygenase-2 expression through PPARgamma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Human immunodeficiency virus type 1-mediated syncytium formation is compatible with adenovirus replication and facilitates efficient dispersion of viral gene products and de novo-synthesized virus particles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Virus-cell and cell-cell fusion

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Early detection of apoptosis using a fluorescent conjugate of annexin V.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Trends in pancreatic cancer mortality in Europe, 1955–1989

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

p53 mutations in colorectal cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Entry pathway of vesicular stomatitis virus into different host cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Cancer statistics, 1999.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Enhanced cytotoxicity without internuclear spread of adenovirus upon cell fusion by measles virus glycoproteins.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

The Birc6 (Bruce) gene regulates p53 and the mitochondrial pathway of apoptosis and is essential for mouse embryonic development

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

A simplified system for generating recombinant adenoviruses

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Structural basis for membrane fusion by enveloped viruses

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Complementary adenoviral vectors for oncolysis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Regulation of p53 stability by Mdm2

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Synergy between expression of fusogenic membrane proteins, chemotherapy and facultative virotherapy in colorectal cancer.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Cancer statistics, 2002

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Entry and uncoating of enveloped viruses

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

A flow cytometric protocol for titering recombinant adenoviral vectors containing the green fluorescent protein

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Combination therapy with conditionally replicating adenovirus and replication defective adenovirus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Genomic Structure of Human Midkine (MK), a Retinoi1c Acid-Responsive Growth/Differentiation Factor1

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Antibody-targeted cell fusion

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

A Cell Line Expressing Vesicular Stomatitis Virus Glycoprotein Fuses at Low p H

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Low-pH induced conformational changes in viral fusion proteins: implications for the fusion mechanism

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Cell surface expression of fusogenic vesicular stomatitis virus G protein from cloned cDNA

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.4161/CBT.6.4.3815

Identifiers

DOI

10.4161/CBT.6.4.3815

1 reference

18 September 2017

1 reference